Cargando…

Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment

The epigenetic machinery deputed to control histone post-translational modifications is frequently dysregulated in cancer cells. With epigenetics being naturally reversible, it represents a good target for therapies directed to restore normal gene expression. Since the discovery of Bromodomain and E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mio, Catia, Bulotta, Stefania, Russo, Diego, Damante, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356452/ https://www.ncbi.nlm.nih.gov/pubmed/30634442 http://dx.doi.org/10.3390/cancers11010061

Ejemplares similares

Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells
por: Maggisano, Valentina, et al.
Publicado: (2022)

Nanoparticles Loaded with the BET Inhibitor JQ1 Block the Growth of Triple Negative Breast Cancer Cells In Vitro and In Vivo
por: Maggisano, Valentina, et al.
Publicado: (2019)

Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
por: Micali, Salvatore, et al.
Publicado: (2014)

Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line
por: Baldan, Federica, et al.
Publicado: (2015)

Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?
por: Choi, Seul-Ki, et al.
Publicado: (2019)

Druggable Targets of Squamous Cell Lung Cancer
por: Kim, Cheol Hyeon
Publicado: (2013)

Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019)

Quercetin Protects Human Thyroid Cells against Cadmium Toxicity
por: Capriglione, Francesca, et al.
Publicado: (2021)

Cysteine metabolic circuitries: druggable targets in cancer
por: Bonifácio, Vasco D. B., et al.
Publicado: (2020)

NK2 homeobox gene cluster: Functions and roles in human diseases
por: Mio, Catia, et al.
Publicado: (2022)

KRAS: A Druggable Target in Colon Cancer Patients
por: Negri, Francesca, et al.
Publicado: (2022)

Optimising breast cancer screening reading: blinding the second reader to the first reader’s decisions
por: Cooper, Jennifer A., et al.
Publicado: (2021)

Druggable genetic targets in endometrial cancer
por: Lehrer, Steven, et al.
Publicado: (2022)

Role of m6A RNA Methylation in Thyroid Cancer Cell Lines
por: Allegri, Lorenzo, et al.
Publicado: (2022)

Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility
por: Mio, Catia, et al.
Publicado: (2021)

Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma
por: Rosignolo, Francesca, et al.
Publicado: (2016)

Targeting KRAS mutant cancers: from druggable therapy to drug resistance
por: Zhu, Chunxiao, et al.
Publicado: (2022)

Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors
por: Montor, Wagner Ricardo, et al.
Publicado: (2018)

Mitochondrial Potassium Channels as Druggable Targets
por: Wrzosek, Antoni, et al.
Publicado: (2020)

Lexical Reading in Dysfluent Readers of German
por: Gangl, Melanie, et al.
Publicado: (2017)

Reading: How Readers Beget Imagining
por: Trasmundi, Sarah Bro, et al.
Publicado: (2020)

Targeting Epigenetic ‘Readers’ with Natural Compounds for Cancer Interception
por: Damiani, Elisabetta, et al.
Publicado: (2020)

Toxoplasmosis: Current and Emerging Parasite Druggable Targets
por: Hajj, Rana El, et al.
Publicado: (2021)

Novel Biomarkers and Druggable Targets in Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Not just a writer: PRC2 as a chromatin reader
por: Uckelmann, Michael, et al.
Publicado: (2021)

Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells
por: Baldan, Federica, et al.
Publicado: (2016)

KRAS mutation: from undruggable to druggable in cancer
por: Huang, Lamei, et al.
Publicado: (2021)

Data-driven analysis and druggability assessment methods to accelerate the identification of novel cancer targets
por: Beis, G., et al.
Publicado: (2022)

Endoplasmic Reticulum Stress and Cancer: Could Unfolded Protein Response Be a Druggable Target for Cancer Therapy?
por: Bonsignore, Gregorio, et al.
Publicado: (2023)

Druggable Drivers of Lung Cancer
por: Fawdar, Shameem, et al.
Publicado: (2013)

From reader to reading teacher : issues and strategies for second language classrooms
por: Aebersold, JoAnn
Publicado: (1997)

Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects
por: Weng, Hao-Jui, et al.
Publicado: (2022)

Richter Syndrome: From Molecular Pathogenesis to Druggable Targets
por: Mouhssine, Samir, et al.
Publicado: (2022)

Intestinal Enteroendocrine Cells: Present and Future Druggable Targets
por: Atanga, Roger, et al.
Publicado: (2023)

Metacognition and Reading: Comparing Three Forms of Metacognition in Normally Developing Readers and Readers with Dyslexia
por: Brunswick, Nicola
Publicado: (2015)

Encouraging reading for pleasure and the comprehensive training for readers
por: Ramírez Leyva, Elsa M.
Publicado: (2016)

Connected Text Reading and Differences in Text Reading Fluency in Adult Readers
por: Wallot, Sebastian, et al.
Publicado: (2013)

Drug Normalization for Cancer Therapeutic and Druggable Genome Target Discovery
por: Jiang, Guoqian, et al.
Publicado: (2015)

New Insights Into DNA Helicases as Druggable Targets for Cancer Therapy
por: Datta, Arindam, et al.
Publicado: (2018)

Integrated genomic analysis to identify druggable targets for pancreatic cancer
por: Mugiyanto, Eko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3cs260l3h5kok0kdvgnqk47787